PL1667693T3 - Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych - Google Patents

Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych

Info

Publication number
PL1667693T3
PL1667693T3 PL04768271T PL04768271T PL1667693T3 PL 1667693 T3 PL1667693 T3 PL 1667693T3 PL 04768271 T PL04768271 T PL 04768271T PL 04768271 T PL04768271 T PL 04768271T PL 1667693 T3 PL1667693 T3 PL 1667693T3
Authority
PL
Poland
Prior art keywords
compositions
methods
therapeutic purposes
lamellar bodies
lamellar
Prior art date
Application number
PL04768271T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0322448.2A external-priority patent/GB0322448D0/en
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Publication of PL1667693T3 publication Critical patent/PL1667693T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL04768271T 2003-09-25 2004-08-31 Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych PL1667693T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0322448.2A GB0322448D0 (en) 2003-09-25 2003-09-25 Using lamellar bodies to modify linear biological macro molecules
US10/827,172 US20050070877A1 (en) 2003-09-25 2004-04-19 Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
PCT/GB2004/003722 WO2005030226A1 (en) 2003-09-25 2004-08-31 Compositions and methods of using lamellar bodies for therapeutic purposes
EP04768271.1A EP1667693B1 (en) 2003-09-25 2004-08-31 Compositions and methods of using lamellar bodies for therapeutic purposes

Publications (1)

Publication Number Publication Date
PL1667693T3 true PL1667693T3 (pl) 2015-12-31

Family

ID=34395440

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04768271T PL1667693T3 (pl) 2003-09-25 2004-08-31 Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych

Country Status (5)

Country Link
EP (1) EP1667693B1 (pl)
AU (1) AU2004275550B2 (pl)
CA (1) CA2540328C (pl)
PL (1) PL1667693T3 (pl)
WO (1) WO2005030226A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210145741A1 (en) * 2018-04-17 2021-05-20 Lamellar Biomedical Limited Antifibrotic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544862B1 (en) * 1991-05-29 1998-03-18 Baxter International Inc. Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal diseases and related conditions
AUPM836794A0 (en) * 1994-09-23 1994-10-20 University Of New England, The Improved method and composition for the treatment of ulcers
AUPN766496A0 (en) * 1996-01-22 1996-02-15 University Of New England, The Method and composition for the potentiation of anti-inflammatory drugs
ATE232388T1 (de) * 1997-12-24 2003-02-15 Britannia Pharmaceuticals Ltd Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes

Also Published As

Publication number Publication date
CA2540328C (en) 2012-11-20
AU2004275550B2 (en) 2011-08-18
AU2004275550A1 (en) 2005-04-07
EP1667693A1 (en) 2006-06-14
CA2540328A1 (en) 2005-04-07
EP1667693B1 (en) 2015-06-24
WO2005030226A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
AU2003259735A8 (en) Small-mer compositions and methods of use
EP1696910A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF FIBROSIS
IL174627A0 (en) Compositions and methods for treatment of burns
IL172194A0 (en) Methods and compositions for treating amyloid-related diseases
EP1663259A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
IL172647A0 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
PT1583542E (pt) Composições e métodos para terapia de combinação antiviral
IL219406A0 (en) Antiloading compositions and methods of selecting same
IL175427A0 (en) Methods and compositions using thalidomide for the treatment and management of cancers and other diseases
EP1613266A4 (en) METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
EP1699431A4 (en) COMPOSITIONS FOR THE TREATMENT OF EARLIER DISEASES AND APPLICATION PROCEDURES
AU2003286741A8 (en) Methods and compositions for diagnosis and therapy of parkin-associated disorders
AU2003299441A8 (en) Nf-hev compositions and methods of use
ZA200600025B (en) Methods and compositions for interferon therapy
EP1663255A4 (en) WITHANAMID AND WITHANOLID COMPOSITIONS AND APPLICATION METHOD THEREFOR
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
GB0303609D0 (en) Novel therapeutic method and compositions
PT1667693E (pt) Composições e métodos para usar corpos lamelares com fins terapêuticos
EP1625141A4 (en) GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF
GB0324523D0 (en) Compositions and methods of treatment
IL166062A0 (en) Compositions and methods for therapeutic treatment
GB0327050D0 (en) Therapeutic methods compositions and uses
PL1667693T3 (pl) Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych
GB0303600D0 (en) Novel therapeutic method and compositions
EP1545539A4 (en) COMPOSITIONS FOR INDUCING INCREASED G (B) -CHIMIOKIN LEVELS AND METHODS OF USE THEREOF